Supraphysiological hyperinsulinemia increases plasma leptin concentrations after 4 h in normal subjects

被引:184
作者
Utriainen, T [1 ]
Malmstrom, R [1 ]
Makimattila, S [1 ]
YkiJarvinen, H [1 ]
机构
[1] UNIV HELSINKI,CENT HOSP,DEPT MED,DIV ENDOCRINOL & DIABETOL,FIN-00290 HELSINKI,FINLAND
关键词
D O I
10.2337/diabetes.45.10.1364
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In rodents, food intake and insulin increase ob gene expression and circulating leptin concentrations, but it is unknown whether insulin regulates plasma leptin concentrations in humans. We measured plasma leptin concentrations in 27 normal subjects (16 men, 11 women; age, 24 +/- 1 years; BMI, 22.6 +/- 0.5 kg/m(2); body fat, 18 +/- 1%) during a 6-h euglycemic hyperinsulinemic clamp (sequential insulin infusions of 1, 2, and 5 mU . kg(-1) . min(-1) for 2 h each). During these insulin infusions, plasma leptin increased hom a basal concentration of 7.4 +/- 1.6 ng/ml by -2 +/- 2, 17 +/- 4, and 50 +/- 6% to 7.2 +/- 1.5 (NS vs. basal), 8.5 +/- 1.7 (P < 0.001), and 10.4 +/- 2.0 ng/ml (P < 0.001), respectively. Of the subjects, eight also participated in a control study where saline was infused for 6 h. In these subjects, plasma leptin increased by 5 +/- 4, 26 +/- 10, and 62 +/- 10% during the insulin infusions, and decreased by 9 +/- 4 (P = 0.07 for change during saline vs. insulin), 13 +/- 4 (P < 0.01), and 17 +/- 4% (P < 0.001) after 2, 4, and 6 h of the saline infusion, respectively. Women had higher plasma leptin concentrations basally and during hyperinsulinemia (P < 0.001) than men, but this difference was entirely accounted for by greater adiposity in women (22 +/- 2 vs. 14 +/- 1%, P < 0.001). These data provide evidence for the insulin regulation of plasma leptin concentrations in humans. This effect requires hours of high insulin concentrations, implying that postprandial satiety is not regulated via changes in plasma leptin concentrations. Insulin may, however, be of importance in the long-term or diurnal regulation of plasma leptin concentrations.
引用
收藏
页码:1364 / 1366
页数:3
相关论文
共 14 条
[1]   Serum immunoreactive leptin concentrations in normal-weight and obese humans [J].
Considine, RV ;
Sinha, MK ;
Heiman, ML ;
Kriauciunas, A ;
Stephens, TW ;
Nyce, MR ;
Ohannesian, JP ;
Marco, CC ;
McKee, LJ ;
Bauer, TL ;
Caro, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :292-295
[2]   THE OB GENE AND INSULIN - A RELATIONSHIP LEADING TO CLUES TO THE UNDERSTANDING OF OBESITY [J].
CUSIN, I ;
SAINSBURY, A ;
DOYLE, P ;
ROHNERJEANRENAUD, F ;
JEANRENAUD, B .
DIABETES, 1995, 44 (12) :1467-1470
[3]   Plasma leptin and insulin relationships in obese and nonobese humans [J].
DagogoJack, S ;
Fanelli, C ;
Paramore, D ;
Brothers, J ;
Landt, M .
DIABETES, 1996, 45 (05) :695-698
[4]  
DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214
[5]   WEIGHT-REDUCING EFFECTS OF THE PLASMA-PROTEIN ENCODED BY THE OBESE GENE [J].
HALAAS, JL ;
GAJIWALA, KS ;
MAFFEI, M ;
COHEN, SL ;
CHAIT, BT ;
RABINOWITZ, D ;
LALLONE, RL ;
BURLEY, SK ;
FRIEDMAN, JM .
SCIENCE, 1995, 269 (5223) :543-546
[6]   Acute and chronic effect of insulin on leptin production in humans - Studies in vivo and in vitro [J].
Kolaczynski, JW ;
Nyce, MR ;
Considine, RV ;
Boden, G ;
Nolan, JJ ;
Henry, R ;
Mudaliar, SR ;
Olefsky, J ;
Caro, JF .
DIABETES, 1996, 45 (05) :699-701
[7]  
Ma ZM, 1996, CLIN CHEM, V42, P942
[8]   REGULATED EXPRESSION OF THE OBESE GENE-PRODUCT (LEPTIN) IN WHITE ADIPOSE-TISSUE AND 3T3-L1 ADIPOCYTES [J].
MACDOUGALD, OA ;
HWANG, CS ;
FAN, HY ;
LANE, MD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (20) :9034-9037
[9]   LEPTIN LEVELS IN HUMAN AND RODENT - MEASUREMENT OF PLASMA LEPTIN AND OB RNA IN OBESE AND WEIGHT-REDUCED SUBJECTS [J].
MAFFEI, M ;
HALAAS, J ;
RAVUSSIN, E ;
PRATLEY, RE ;
LEE, GH ;
ZHANG, Y ;
FEI, H ;
KIM, S ;
LALLONE, R ;
RANGANATHAN, S ;
KERN, PA ;
FRIEDMAN, JM .
NATURE MEDICINE, 1995, 1 (11) :1155-1161
[10]   HUMAN OBESE GENE-EXPRESSION - ADIPOCYTE-SPECIFIC EXPRESSION AND REGIONAL DIFFERENCES IN THE ADIPOSE-TISSUE [J].
MASUZAKI, H ;
OGAWA, Y ;
ISSE, N ;
SATOH, N ;
OKAZAKI, T ;
SHIGEMOTO, M ;
MORI, K ;
TAMURA, N ;
HOSODA, K ;
YOSHIMASA, Y ;
JINGAMI, H ;
KAWADA, T ;
NAKAO, K .
DIABETES, 1995, 44 (07) :855-858